Genome Editing - Global Market Outlook (2016-2022)
According to Stratistics MRC, the Global Genome Editing market is estimated at $2098.9 million in 2015 and is expected to reach $5367.64 million by 2022 growing at a CAGR of 14.3% from 2015 to 2022. Increasing investment and more focus on research and development by companies for new treatment are the key factors driving the market growth. Strict rules imposed by governments across the regions is restraining genome editing market. Technological advancements generate pool of opportunities for market growth.
North America captured huge market share owing to the increase in biotechnology and pharmaceutical industries in United States. However, Asia Pacific is anticipated to be the fastest growing region with highest CAGR during forecast period, because of rapid increase in research and development this region. Pharmaceutical and Biotechnology Companies in end user segment holds largest share in the market.
Some of the key players in the market are Sangamo Biosciences, Inc., Origene Technologies, Inc., MERCK KGAA, Thermo Fisher Scientific, Inc., New England Biolabs, Inc., CELLECTIS S.A., Horizon Discovery Group Plc, Lonza Group Ltd., APPLIED STEMCELL INC., Sigma-Aldrich Corporation, Transposagen Biopharmaceuticals, Inc., Integrated DNA Technologies, Inc and Genscript USA Inc.Products and Services Covered:
North America captured huge market share owing to the increase in biotechnology and pharmaceutical industries in United States. However, Asia Pacific is anticipated to be the fastest growing region with highest CAGR during forecast period, because of rapid increase in research and development this region. Pharmaceutical and Biotechnology Companies in end user segment holds largest share in the market.
Some of the key players in the market are Sangamo Biosciences, Inc., Origene Technologies, Inc., MERCK KGAA, Thermo Fisher Scientific, Inc., New England Biolabs, Inc., CELLECTIS S.A., Horizon Discovery Group Plc, Lonza Group Ltd., APPLIED STEMCELL INC., Sigma-Aldrich Corporation, Transposagen Biopharmaceuticals, Inc., Integrated DNA Technologies, Inc and Genscript USA Inc.Products and Services Covered:
- Genome Editing Services
- Software
- Reagents, Enzymes and Consumables
- Delivery Tools
- Genome Editing Tools And Kits
- Other Reagents, Enzymes And Consumables
- Instruments
- Cell Lines and Animal Models
Technologies Covered:- Clustered Regularly Interspaced Short Palindromic Repeats (Crispr/Cas9)
- Crispr Dcas9
- Wt Crispr/Cas9
- Crispr/Cas9 Nickase
- Transcription Activator-Like Effector Nucleases (Talen)
- Zinc Finger Nuclease (Zfn)
- Antisense Technology
- Other Technologies
- Arcus (Homing Endonuclease) And Megatal
- Recombinant Adeno-Associated Virus (R Aav)
- Targatt And Rapid Trait Development System (Rtds)
- Piggybac Transposase And Sleeping Beauty Transposon
- Plant Biotechnology/Agriculture
- Drug Discovery and Development
- Clinical
- Pre-Clinical
- Basic Research
- Genomic Visualization
- Genomic Screening
- Transcription Activation/Repression
- Animal Biotechnology
- Livestock
- Animal Health
- Other Animal Biotechnology
- Cell Line Engineering
- Pharmaceutical And Biotechnology Companies
- Academic And Government Research Institutes
- Plant Biotechnology Companies
- Others End Users
- Contract Research Organizations (Cro)
- Animal Biotechnology
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- Italy
- UK
- Spain
- Rest of Europe
- Asia Pacific
- Japan
- China
- India
- Australia
- New Zealand
- Rest of Asia Pacific
- Rest of the World
- Middle East
- Brazil
- Argentina
- South Africa
- Egypt
- Market share assessments for the regional and country level segments
- Market share analysis of the top industry players
- Strategic recommendations for the new entrants
- Market forecasts for a minimum of 7 years of all the mentioned segments, sub segments and the regional markets
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements
1 EXECUTIVE SUMMARY
2 PREFACE
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions
3 MARKET TREND ANALYSIS
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Technology Analysis
3.7 Application Analysis
3.8 End User Analysis
3.9 Emerging Markets
4 PORTERS FIVE FORCE ANALYSIS
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 GLOBAL GENOME EDITING MARKET, BY PRODUCTS AND SERVICES
5.1 Introduction
5.2 Genome Editing Services
5.3 Software
5.4 Reagents, Enzymes And Consumables
5.4.1 Delivery Tools
5.4.2 Genome Editing Tools And Kits
5.4.3 Other Reagents, Enzymes And Consumables
5.5 Instruments
5.6 Cell Lines And Animal Models
6 GLOBAL GENOME EDITING MARKET, BY TECHNOLOGY
6.1 Introduction
6.2 Clustered Regularly Interspaced Short Palindromic Repeats (Crispr/Cas9)
6.2.1 Crispr Dcas9
6.2.2 Wt Crispr/Cas9
6.2.3 Crispr/Cas9 Nickase
6.3 Transcription Activator-Like Effector Nucleases (Talen)
6.4 Zinc Finger Nuclease (Zfn)
6.5 Antisense Technology
6.6 Other Technologies
6.6.1 Arcus (Homing Endonuclease) And Megatal
6.6.2 Recombinant Adeno-Associated Virus (R Aav)
6.6.3 Targatt And Rapid Trait Development System (Rtds)
6.6.4 Piggybac Transposase And Sleeping Beauty Transposon
7 GLOBAL GENOME EDITING MARKET, BY APPLICATION
7.1 Introduction
7.2 Plant Biotechnology/Agriculture
7.3 Drug Discovery And Development
7.3.1 Clinical
7.3.2 Pre-Clinical
7.4 Basic Research
7.4.1 Genomic Visualization
7.4.2 Genomic Screening
7.4.3 Transcription Activation/Repression
7.5 Animal Biotechnology
7.5.1 Livestock
7.5.2 Animal Health
7.5.3 Other Animal Biotechnology
7.6 Cell Line Engineering
8 GLOBAL GENOME EDITING MARKET, BY END USER
8.1 Introduction
8.2 Pharmaceutical And Biotechnology Companies
8.3 Academic And Government Research Institutes
8.4 Plant Biotechnology Companies
8.5 Others End Users
8.5.1 Contract Research Organizations (Cro)
8.5.2 Animal Biotechnology
9 GLOBAL GENOME EDITING MARKET, BY GEOGRAPHY
9.1 North America
9.1.1 US
9.1.2 Canada
9.1.3 Mexico
9.2 Europe
9.2.1 Germany
9.2.2 France
9.2.3 Italy
9.2.4 UK
9.2.5 Spain
9.2.6 Rest of Europe
9.3 Asia Pacific
9.3.1 Japan
9.3.2 China
9.3.3 India
9.3.4 Australia
9.3.5 New Zealand
9.3.6 Rest of Asia Pacific
9.4 Rest of the World
9.4.1 Middle East
9.4.2 Brazil
9.4.3 Argentina
9.4.4 South Africa
9.4.5 Egypt
10 KEY DEVELOPMENTS
10.1 Agreements, Partnerships, Collaborations and Joint Ventures
10.2 Acquisitions & Mergers
10.3 New Product Launch
10.4 Expansions
10.5 Other Key Strategies
11 COMPANY PROFILING
11.1 Sangamo Biosciences, Inc.
11.2 Origene Technologies, Inc. (U.S.)
11.3 MERCK KGAA
11.4 Thermo Fisher Scientific, Inc.
11.5 New England Biolabs, Inc. (U.S.)
11.6 CELLECTIS S.A.
11.7 Horizon Discovery Group Plc
11.8 Lonza Group Ltd. (Switzerland)
11.9 APPLIED STEMCELL INC.
11.10 Sigma-Aldrich Corporation
11.11 Transposagen Biopharmaceuticals, Inc. (U.S.).
11.12 Integrated Dna Technologies, Inc.
11.13 Genscript USA Inc.
2 PREFACE
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions
3 MARKET TREND ANALYSIS
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Technology Analysis
3.7 Application Analysis
3.8 End User Analysis
3.9 Emerging Markets
4 PORTERS FIVE FORCE ANALYSIS
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 GLOBAL GENOME EDITING MARKET, BY PRODUCTS AND SERVICES
5.1 Introduction
5.2 Genome Editing Services
5.3 Software
5.4 Reagents, Enzymes And Consumables
5.4.1 Delivery Tools
5.4.2 Genome Editing Tools And Kits
5.4.3 Other Reagents, Enzymes And Consumables
5.5 Instruments
5.6 Cell Lines And Animal Models
6 GLOBAL GENOME EDITING MARKET, BY TECHNOLOGY
6.1 Introduction
6.2 Clustered Regularly Interspaced Short Palindromic Repeats (Crispr/Cas9)
6.2.1 Crispr Dcas9
6.2.2 Wt Crispr/Cas9
6.2.3 Crispr/Cas9 Nickase
6.3 Transcription Activator-Like Effector Nucleases (Talen)
6.4 Zinc Finger Nuclease (Zfn)
6.5 Antisense Technology
6.6 Other Technologies
6.6.1 Arcus (Homing Endonuclease) And Megatal
6.6.2 Recombinant Adeno-Associated Virus (R Aav)
6.6.3 Targatt And Rapid Trait Development System (Rtds)
6.6.4 Piggybac Transposase And Sleeping Beauty Transposon
7 GLOBAL GENOME EDITING MARKET, BY APPLICATION
7.1 Introduction
7.2 Plant Biotechnology/Agriculture
7.3 Drug Discovery And Development
7.3.1 Clinical
7.3.2 Pre-Clinical
7.4 Basic Research
7.4.1 Genomic Visualization
7.4.2 Genomic Screening
7.4.3 Transcription Activation/Repression
7.5 Animal Biotechnology
7.5.1 Livestock
7.5.2 Animal Health
7.5.3 Other Animal Biotechnology
7.6 Cell Line Engineering
8 GLOBAL GENOME EDITING MARKET, BY END USER
8.1 Introduction
8.2 Pharmaceutical And Biotechnology Companies
8.3 Academic And Government Research Institutes
8.4 Plant Biotechnology Companies
8.5 Others End Users
8.5.1 Contract Research Organizations (Cro)
8.5.2 Animal Biotechnology
9 GLOBAL GENOME EDITING MARKET, BY GEOGRAPHY
9.1 North America
9.1.1 US
9.1.2 Canada
9.1.3 Mexico
9.2 Europe
9.2.1 Germany
9.2.2 France
9.2.3 Italy
9.2.4 UK
9.2.5 Spain
9.2.6 Rest of Europe
9.3 Asia Pacific
9.3.1 Japan
9.3.2 China
9.3.3 India
9.3.4 Australia
9.3.5 New Zealand
9.3.6 Rest of Asia Pacific
9.4 Rest of the World
9.4.1 Middle East
9.4.2 Brazil
9.4.3 Argentina
9.4.4 South Africa
9.4.5 Egypt
10 KEY DEVELOPMENTS
10.1 Agreements, Partnerships, Collaborations and Joint Ventures
10.2 Acquisitions & Mergers
10.3 New Product Launch
10.4 Expansions
10.5 Other Key Strategies
11 COMPANY PROFILING
11.1 Sangamo Biosciences, Inc.
11.2 Origene Technologies, Inc. (U.S.)
11.3 MERCK KGAA
11.4 Thermo Fisher Scientific, Inc.
11.5 New England Biolabs, Inc. (U.S.)
11.6 CELLECTIS S.A.
11.7 Horizon Discovery Group Plc
11.8 Lonza Group Ltd. (Switzerland)
11.9 APPLIED STEMCELL INC.
11.10 Sigma-Aldrich Corporation
11.11 Transposagen Biopharmaceuticals, Inc. (U.S.).
11.12 Integrated Dna Technologies, Inc.
11.13 Genscript USA Inc.
LIST OF TABLES
1 Global Genome Editing Market Outlook, By Region (2013-2022) ($MN)
2 Global Genome Editing Market Outlook, By Products And Services (2013-2022) ($MN)
3 Global Genome Editing Market Outlook, By Genome Editing Services (2013-2022) ($MN)
4 Global Genome Editing Market Outlook, By Software (2013-2022) ($MN)
5 Global Genome Editing Market Outlook, By Reagents, Enzymes And Consumables (2013-2022) ($MN)
6 Global Genome Editing Market Outlook, By Delivery Tools (2013-2022) ($MN)
7 Global Genome Editing Market Outlook, By Genome Editing Tools And Kits (2013-2022) ($MN)
8 Global Genome Editing Market Outlook, By Other Reagents, Enzymes And Consumables (2013-2022) ($MN)
9 Global Genome Editing Market Outlook, By Instruments (2013-2022) ($MN)
10 Global Genome Editing Market Outlook, By Cell Lines And Animal Models (2013-2022) ($MN)
11 Global Genome Editing Market Outlook, By Technology (2013-2022) ($MN)
12 Global Genome Editing Market Outlook, By Clustered Regularly Interspaced Short Palindromic Repeats (Crispr/Cas9) (2013-2022) ($MN)
13 Global Genome Editing Market Outlook, By Crispr Dcas9 (2013-2022) ($MN)
14 Global Genome Editing Market Outlook, By Wt Crispr/Cas9 (2013-2022) ($MN)
15 Global Genome Editing Market Outlook, By Crispr/Cas9 Nickase (2013-2022) ($MN)
16 Global Genome Editing Market Outlook, By Transcription Activator-Like Effector Nucleases (Talen) (2013-2022) ($MN)
17 Global Genome Editing Market Outlook, By Zinc Finger Nuclease (Zfn) (2013-2022) ($MN)
18 Global Genome Editing Market Outlook, By Antisense Technology (2013-2022) ($MN)
19 Global Genome Editing Market Outlook, By Other Technologies (2013-2022) ($MN)
20 Global Genome Editing Market Outlook, By Arcus (Homing Endonuclease) And Megatal (2013-2022) ($MN)
21 Global Genome Editing Market Outlook, By Recombinant Adeno-Associated Virus (R Aav) (2013-2022) ($MN)
22 Global Genome Editing Market Outlook, By Targatt And Rapid Trait Development System (Rtds) (2013-2022) ($MN)
23 Global Genome Editing Market Outlook, By Piggybac Transposase And Sleeping Beauty Transposon (2013-2022) ($MN)
24 Global Genome Editing Market Outlook, By Application (2013-2022) ($MN)
25 Global Genome Editing Market Outlook, By Plant Biotechnology/Agriculture (2013-2022) ($MN)
26 Global Genome Editing Market Outlook, By Drug Discovery And Development (2013-2022) ($MN)
27 Global Genome Editing Market Outlook, By Clinical (2013-2022) ($MN)
28 Global Genome Editing Market Outlook, By Pre-Clinical (2013-2022) ($MN)
29 Global Genome Editing Market Outlook, By Basic Research (2013-2022) ($MN)
30 Global Genome Editing Market Outlook, By Genomic Visualization (2013-2022) ($MN)
31 Global Genome Editing Market Outlook, By Genomic Screening (2013-2022) ($MN)
32 Global Genome Editing Market Outlook, By Transcription Activation/Repression (2013-2022) ($MN)
33 Global Genome Editing Market Outlook, By Animal Biotechnology (2013-2022) ($MN)
34 Global Genome Editing Market Outlook, By Livestock (2013-2022) ($MN)
35 Global Genome Editing Market Outlook, By Animal Health (2013-2022) ($MN)
36 Global Genome Editing Market Outlook, By Other Animal Biotechnology (2013-2022) ($MN)
37 Global Genome Editing Market Outlook, By Cell Line Engineering (2013-2022) ($MN)
38 Global Genome Editing Market Outlook, By End User (2013-2022) ($MN)
39 Global Genome Editing Market Outlook, By Pharmaceutical And Biotechnology Companies (2013-2022) ($MN)
40 Global Genome Editing Market Outlook, By Academic And Government Research Institutes (2013-2022) ($MN)
41 Global Genome Editing Market Outlook, By Plant Biotechnology Companies (2013-2022) ($MN)
42 Global Genome Editing Market Outlook, By Others End Users (2013-2022) ($MN)
43 Global Genome Editing Market Outlook, By Contract Research Organizations (Cro) (2013-2022) ($MN)
44 Global Genome Editing Market Outlook, By Animal Biotechnology (2013-2022) ($MN)
45 North America Genome Editing Market Outlook, By Country (2013-2022) ($MN)
46 North America Genome Editing Market Outlook, By Products And Services (2013-2022) ($MN)
47 North America Genome Editing Market Outlook, By Genome Editing Services (2013-2022) ($MN)
48 North America Genome Editing Market Outlook, By Software (2013-2022) ($MN)
49 North America Genome Editing Market Outlook, By Reagents, Enzymes And Consumables (2013-2022) ($MN)
50 North America Genome Editing Market Outlook, By Delivery Tools (2013-2022) ($MN)
51 North America Genome Editing Market Outlook, By Genome Editing Tools And Kits (2013-2022) ($MN)
52 North America Genome Editing Market Outlook, By Other Reagents, Enzymes And Consumables (2013-2022) ($MN)
53 North America Genome Editing Market Outlook, By Instruments (2013-2022) ($MN)
54 North America Genome Editing Market Outlook, By Cell Lines And Animal Models (2013-2022) ($MN)
55 North America Genome Editing Market Outlook, By Technology (2013-2022) ($MN)
56 North America Genome Editing Market Outlook, By Clustered Regularly Interspaced Short Palindromic Repeats (Crispr/Cas9) (2013-2022) ($MN)
57 North America Genome Editing Market Outlook, By Crispr Dcas9 (2013-2022) ($MN)
58 North America Genome Editing Market Outlook, By Wt Crispr/Cas9 (2013-2022) ($MN)
59 North America Genome Editing Market Outlook, By Crispr/Cas9 Nickase (2013-2022) ($MN)
60 North America Genome Editing Market Outlook, By Transcription Activator-Like Effector Nucleases (Talen) (2013-2022) ($MN)
61 North America Genome Editing Market Outlook, By Zinc Finger Nuclease (Zfn) (2013-2022) ($MN)
62 North America Genome Editing Market Outlook, By Antisense Technology (2013-2022) ($MN)
63 North America Genome Editing Market Outlook, By Other Technologies (2013-2022) ($MN)
64 North America Genome Editing Market Outlook, By Arcus (Homing Endonuclease) And Megatal (2013-2022) ($MN)
65 North America Genome Editing Market Outlook, By Recombinant Adeno-Associated Virus (R Aav) (2013-2022) ($MN)
66 North America Genome Editing Market Outlook, By Targatt And Rapid Trait Development System (Rtds) (2013-2022) ($MN)
67 North America Genome Editing Market Outlook, By Piggybac Transposase And Sleeping Beauty Transposon (2013-2022) ($MN)
68 North America Genome Editing Market Outlook, By Application (2013-2022) ($MN)
69 North America Genome Editing Market Outlook, By Plant Biotechnology/Agriculture (2013-2022) ($MN)
70 North America Genome Editing Market Outlook, By Drug Discovery And Development (2013-2022) ($MN)
71 North America Genome Editing Market Outlook, By Clinical (2013-2022) ($MN)
72 North America Genome Editing Market Outlook, By Pre-Clinical (2013-2022) ($MN)
73 North America Genome Editing Market Outlook, By Basic Research (2013-2022) ($MN)
74 North America Genome Editing Market Outlook, By Genomic Visualization (2013-2022) ($MN)
75 North America Genome Editing Market Outlook, By Genomic Screening (2013-2022) ($MN)
76 North America Genome Editing Market Outlook, By Transcription Activation/Repression (2013-2022) ($MN)
77 North America Genome Editing Market Outlook, By Animal Biotechnology (2013-2022) ($MN)
78 North America Genome Editing Market Outlook, By Livestock (2013-2022) ($MN)
79 North America Genome Editing Market Outlook, By Animal Health (2013-2022) ($MN)
80 North America Genome Editing Market Outlook, By Other Animal Biotechnology (2013-2022) ($MN)
81 North America Genome Editing Market Outlook, By Cell Line Engineering (2013-2022) ($MN)
82 North America Genome Editing Market Outlook, By End User (2013-2022) ($MN)
83 North America Genome Editing Market Outlook, By Pharmaceutical And Biotechnology Companies (2013-2022) ($MN)
84 North America Genome Editing Market Outlook, By Academic And Government Research Institutes (2013-2022) ($MN)
85 North America Genome Editing Market Outlook, By Plant Biotechnology Companies (2013-2022) ($MN)
86 North America Genome Editing Market Outlook, By Others End Users (2013-2022) ($MN)
87 North America Genome Editing Market Outlook, By Contract Research Organizations (Cro) (2013-2022) ($MN)
88 North America Genome Editing Market Outlook, By Animal Biotechnology (2013-2022) ($MN)
89 Europe Genome Editing Market Outlook, By Country (2013-2022) ($MN)
90 Europe Genome Editing Market Outlook, By Products And Services (2013-2022) ($MN)
91 Europe Genome Editing Market Outlook, By Genome Editing Services (2013-2022) ($MN)
92 Europe Genome Editing Market Outlook, By Software (2013-2022) ($MN)
93 Europe Genome Editing Market Outlook, By Reagents, Enzymes And Consumables (2013-2022) ($MN)
94 Europe Genome Editing Market Outlook, By Delivery Tools (2013-2022) ($MN)
95 Europe Genome Editing Market Outlook, By Genome Editing Tools And Kits (2013-2022) ($MN)
96 Europe Genome Editing Market Outlook, By Other Reagents, Enzymes And Consumables (2013-2022) ($MN)
97 Europe Genome Editing Market Outlook, By Instruments (2013-2022) ($MN)
98 Europe Genome Editing Market Outlook, By Cell Lines And Animal Models (2013-2022) ($MN)
99 Europe Genome Editing Market Outlook, By Technology (2013-2022) ($MN)
100 Europe Genome Editing Market Outlook, By Clustered Regularly Interspaced Short Palindromic Repeats (Crispr/Cas9) (2013-2022) ($MN)
101 Europe Genome Editing Market Outlook, By Crispr Dcas9 (2013-2022) ($MN)
102 Europe Genome Editing Market Outlook, By Wt Crispr/Cas9 (2013-2022) ($MN)
103 Europe Genome Editing Market Outlook, By Crispr/Cas9 Nickase (2013-2022) ($MN)
104 Europe Genome Editing Market Outlook, By Transcription Activator-Like Effector Nucleases (Talen) (2013-2022) ($MN)
105 Europe Genome Editing Market Outlook, By Zinc Finger Nuclease (Zfn) (2013-2022) ($MN)
106 Europe Genome Editing Market Outlook, By Antisense Technology (2013-2022) ($MN)
107 Europe Genome Editing Market Outlook, By Other Technologies (2013-2022) ($MN)
108 Europe Genome Editing Market Outlook, By Arcus (Homing Endonuclease) And Megatal (2013-2022) ($MN)
109 Europe Genome Editing Market Outlook, By Recombinant Adeno-Associated Virus (R Aav) (2013-2022) ($MN)
110 Europe Genome Editing Market Outlook, By Targatt And Rapid Trait Development System (Rtds) (2013-2022) ($MN)
111 Europe Genome Editing Market Outlook, By Piggybac Transposase And Sleeping Beauty Transposon (2013-2022) ($MN)
112 Europe Genome Editing Market Outlook, By Application (2013-2022) ($MN)
113 Europe Genome Editing Market Outlook, By Plant Biotechnology/Agriculture (2013-2022) ($MN)
114 Europe Genome Editing Market Outlook, By Drug Discovery And Development (2013-2022) ($MN)
115 Europe Genome Editing Market Outlook, By Clinical (2013-2022) ($MN)
116 Europe Genome Editing Market Outlook, By Pre-Clinical (2013-2022) ($MN)
117 Europe Genome Editing Market Outlook, By Basic Research (2013-2022) ($MN)
118 Europe Genome Editing Market Outlook, By Genomic Visualization (2013-2022) ($MN)
119 Europe Genome Editing Market Outlook, By Genomic Screening (2013-2022) ($MN)
120 Europe Genome Editing Market Outlook, By Transcription Activation/Repression (2013-2022) ($MN)
121 Europe Genome Editing Market Outlook, By Animal Biotechnology (2013-2022) ($MN)
122 Europe Genome Editing Market Outlook, By Livestock (2013-2022) ($MN)
123 Europe Genome Editing Market Outlook, By Animal Health (2013-2022) ($MN)
124 Europe Genome Editing Market Outlook, By Other Animal Biotechnology (2013-2022) ($MN)
125 Europe Genome Editing Market Outlook, By Cell Line Engineering (2013-2022) ($MN)
126 Europe Genome Editing Market Outlook, By End User (2013-2022) ($MN)
127 Europe Genome Editing Market Outlook, By Pharmaceutical And Biotechnology Companies (2013-2022) ($MN)
128 Europe Genome Editing Market Outlook, By Academic And Government Research Institutes (2013-2022) ($MN)
129 Europe Genome Editing Market Outlook, By Plant Biotechnology Companies (2013-2022) ($MN)
130 Europe Genome Editing Market Outlook, By Others End Users (2013-2022) ($MN)
131 Europe Genome Editing Market Outlook, By Contract Research Organizations (Cro) (2013-2022) ($MN)
132 Europe Genome Editing Market Outlook, By Animal Biotechnology (2013-2022) ($MN)
133 Asia Pacific Genome Editing Market Outlook, By Country (2013-2022) ($MN)
134 Asia Pacific Genome Editing Market Outlook, By Products And Services (2013-2022) ($MN)
135 Asia Pacific Genome Editing Market Outlook, By Genome Editing Services (2013-2022) ($MN)
136 Asia Pacific Genome Editing Market Outlook, By Software (2013-2022) ($MN)
137 Asia Pacific Genome Editing Market Outlook, By Reagents, Enzymes And Consumables (2013-2022) ($MN)
138 Asia Pacific Genome Editing Market Outlook, By Delivery Tools (2013-2022) ($MN)
139 Asia Pacific Genome Editing Market Outlook, By Genome Editing Tools And Kits (2013-2022) ($MN)
140 Asia Pacific Genome Editing Market Outlook, By Other Reagents, Enzymes And Consumables (2013-2022) ($MN)
141 Asia Pacific Genome Editing Market Outlook, By Instruments (2013-2022) ($MN)
142 Asia Pacific Genome Editing Market Outlook, By Cell Lines And Animal Models (2013-2022) ($MN)
143 Asia Pacific Genome Editing Market Outlook, By Technology (2013-2022) ($MN)
144 Asia Pacific Genome Editing Market Outlook, By Clustered Regularly Interspaced Short Palindromic Repeats (Crispr/Cas9) (2013-2022) ($MN)
145 Asia Pacific Genome Editing Market Outlook, By Crispr Dcas9 (2013-2022) ($MN)
146 Asia Pacific Genome Editing Market Outlook, By Wt Crispr/Cas9 (2013-2022) ($MN)
147 Asia Pacific Genome Editing Market Outlook, By Crispr/Cas9 Nickase (2013-2022) ($MN)
148 Asia Pacific Genome Editing Market Outlook, By Transcription Activator-Like Effector Nucleases (Talen) (2013-2022) ($MN)
149 Asia Pacific Genome Editing Market Outlook, By Zinc Finger Nuclease (Zfn) (2013-2022) ($MN)
150 Asia Pacific Genome Editing Market Outlook, By Antisense Technology (2013-2022) ($MN)
151 Asia Pacific Genome Editing Market Outlook, By Other Technologies (2013-2022) ($MN)
152 Asia Pacific Genome Editing Market Outlook, By Arcus (Homing Endonuclease) And Megatal (2013-2022) ($MN)
153 Asia Pacific Genome Editing Market Outlook, By Recombinant Adeno-Associated Virus (R Aav) (2013-2022) ($MN)
154 Asia Pacific Genome Editing Market Outlook, By Targatt And Rapid Trait Development System (Rtds) (2013-2022) ($MN)
155 Asia Pacific Genome Editing Market Outlook, By Piggybac Transposase And Sleeping Beauty Transposon (2013-2022) ($MN)
156 Asia Pacific Genome Editing Market Outlook, By Application (2013-2022) ($MN)
157 Asia Pacific Genome Editing Market Outlook, By Plant Biotechnology/Agriculture (2013-2022) ($MN)
158 Asia Pacific Genome Editing Market Outlook, By Drug Discovery And Development (2013-2022) ($MN)
159 Asia Pacific Genome Editing Market Outlook, By Clinical (2013-2022) ($MN)
160 Asia Pacific Genome Editing Market Outlook, By Pre-Clinical (2013-2022) ($MN)
161 Asia Pacific Genome Editing Market Outlook, By Basic Research (2013-2022) ($MN)
162 Asia Pacific Genome Editing Market Outlook, By Genomic Visualization (2013-2022) ($MN)
163 Asia Pacific Genome Editing Market Outlook, By Genomic Screening (2013-2022) ($MN)
164 Asia Pacific Genome Editing Market Outlook, By Transcription Activation/Repression (2013-2022) ($MN)
165 Asia Pacific Genome Editing Market Outlook, By Animal Biotechnology (2013-2022) ($MN)
166 Asia Pacific Genome Editing Market Outlook, By Livestock (2013-2022) ($MN)
167 Asia Pacific Genome Editing Market Outlook, By Animal Health (2013-2022) ($MN)
168 Asia Pacific Genome Editing Market Outlook, By Other Animal Biotechnology (2013-2022) ($MN)
169 Asia Pacific Genome Editing Market Outlook, By Cell Line Engineering (2013-2022) ($MN)
170 Asia Pacific Genome Editing Market Outlook, By End User (2013-2022) ($MN)
171 Asia Pacific Genome Editing Market Outlook, By Pharmaceutical And Biotechnology Companies (2013-2022) ($MN)
172 Asia Pacific Genome Editing Market Outlook, By Academic And Government Research Institutes (2013-2022) ($MN)
173 Asia Pacific Genome Editing Market Outlook, By Plant Biotechnology Companies (2013-2022) ($MN)
174 Asia Pacific Genome Editing Market Outlook, By Others End Users (2013-2022) ($MN)
175 Asia Pacific Genome Editing Market Outlook, By Contract Research Organizations (Cro) (2013-2022) ($MN)
176 Asia Pacific Genome Editing Market Outlook, By Animal Biotechnology (2013-2022) ($MN)
177 RoW Genome Editing Market Outlook, By Country (2013-2022) ($MN)
178 RoW Genome Editing Market Outlook, By Products And Services (2013-2022) ($MN)
179 RoW Genome Editing Market Outlook, By Genome Editing Services (2013-2022) ($MN)
180 RoW Genome Editing Market Outlook, By Software (2013-2022) ($MN)
181 RoW Genome Editing Market Outlook, By Reagents, Enzymes And Consumables (2013-2022) ($MN)
182 RoW Genome Editing Market Outlook, By Delivery Tools (2013-2022) ($MN)
183 RoW Genome Editing Market Outlook, By Genome Editing Tools and Kits (2013-2022) ($MN)
184 RoW Genome Editing Market Outlook, By Other Reagents, Enzymes and Consumables (2013-2022) ($MN)
185 RoW Genome Editing Market Outlook, By Instruments (2013-2022) ($MN)
186 RoW Genome Editing Market Outlook, By Cell Lines and Animal Models (2013-2022) ($MN)
187 RoW Genome Editing Market Outlook, By Technology (2013-2022) ($MN)
188 RoW Genome Editing Market Outlook, By Clustered Regularly Interspaced Short Palindromic Repeats (Crispr/Cas9) (2013-2022) ($MN)
189 RoW Genome Editing Market Outlook, By Crispr Dcas9 (2013-2022) ($MN)
190 RoW Genome Editing Market Outlook, By Wt Crispr/Cas9 (2013-2022) ($MN)
191 RoW Genome Editing Market Outlook, By Crispr/Cas9 Nickase (2013-2022) ($MN)
192 RoW Genome Editing Market Outlook, By Transcription Activator-Like Effector Nucleases (Talen) (2013-2022) ($MN)
193 RoW Genome Editing Market Outlook, By Zinc Finger Nuclease (Zfn) (2013-2022) ($MN)
194 RoW Genome Editing Market Outlook, By Antisense Technology (2013-2022) ($MN)
195 RoW Genome Editing Market Outlook, By Other Technologies (2013-2022) ($MN)
196 RoW Genome Editing Market Outlook, By Arcus (Homing Endonuclease) And Megatal (2013-2022) ($MN)
197 RoW Genome Editing Market Outlook, By Recombinant Adeno-Associated Virus (R Aav) (2013-2022) ($MN)
198 RoW Genome Editing Market Outlook, By Targatt and Rapid Trait Development System (Rtds) (2013-2022) ($MN)
199 RoW Genome Editing Market Outlook, By Piggybac Transposase And Sleeping Beauty Transposon (2013-2022) ($MN)
200 RoW Genome Editing Market Outlook, By Application (2013-2022) ($MN)
201 RoW Genome Editing Market Outlook, By Plant Biotechnology/Agriculture (2013-2022) ($MN)
202 RoW Genome Editing Market Outlook, By Drug Discovery and Development (2013-2022) ($MN)
203 RoW Genome Editing Market Outlook, By Clinical (2013-2022) ($MN)
204 RoW Genome Editing Market Outlook, By Pre-Clinical (2013-2022) ($MN)
205 RoW Genome Editing Market Outlook, By Basic Research (2013-2022) ($MN)
206 RoW Genome Editing Market Outlook, By Genomic Visualization (2013-2022) ($MN)
207 RoW Genome Editing Market Outlook, By Genomic Screening (2013-2022) ($MN)
208 RoW Genome Editing Market Outlook, By Transcription Activation/Repression (2013-2022) ($MN)
209 RoW Genome Editing Market Outlook, By Animal Biotechnology (2013-2022) ($MN)
210 RoW Genome Editing Market Outlook, By Livestock (2013-2022) ($MN)
211 RoW Genome Editing Market Outlook, By Animal Health (2013-2022) ($MN)
212 RoW Genome Editing Market Outlook, By Other Animal Biotechnology (2013-2022) ($MN)
213 RoW Genome Editing Market Outlook, By Cell Line Engineering (2013-2022) ($MN)
214 RoW Genome Editing Market Outlook, By End User (2013-2022) ($MN)
215 RoW Genome Editing Market Outlook, By Pharmaceutical and Biotechnology Companies (2013-2022) ($MN)
216 RoW Genome Editing Market Outlook, By Academic and Government Research Institutes (2013-2022) ($MN)
217 RoW Genome Editing Market Outlook, By Plant Biotechnology Companies (2013-2022) ($MN)
218 RoW Genome Editing Market Outlook, By Others End Users (2013-2022) ($MN)
219 RoW Genome Editing Market Outlook, By Contract Research Organizations (Cro) (2013-2022) ($MN)
220 RoW Genome Editing Market Outlook, By Animal Biotechnology (2013-2022) ($MN)
1 Global Genome Editing Market Outlook, By Region (2013-2022) ($MN)
2 Global Genome Editing Market Outlook, By Products And Services (2013-2022) ($MN)
3 Global Genome Editing Market Outlook, By Genome Editing Services (2013-2022) ($MN)
4 Global Genome Editing Market Outlook, By Software (2013-2022) ($MN)
5 Global Genome Editing Market Outlook, By Reagents, Enzymes And Consumables (2013-2022) ($MN)
6 Global Genome Editing Market Outlook, By Delivery Tools (2013-2022) ($MN)
7 Global Genome Editing Market Outlook, By Genome Editing Tools And Kits (2013-2022) ($MN)
8 Global Genome Editing Market Outlook, By Other Reagents, Enzymes And Consumables (2013-2022) ($MN)
9 Global Genome Editing Market Outlook, By Instruments (2013-2022) ($MN)
10 Global Genome Editing Market Outlook, By Cell Lines And Animal Models (2013-2022) ($MN)
11 Global Genome Editing Market Outlook, By Technology (2013-2022) ($MN)
12 Global Genome Editing Market Outlook, By Clustered Regularly Interspaced Short Palindromic Repeats (Crispr/Cas9) (2013-2022) ($MN)
13 Global Genome Editing Market Outlook, By Crispr Dcas9 (2013-2022) ($MN)
14 Global Genome Editing Market Outlook, By Wt Crispr/Cas9 (2013-2022) ($MN)
15 Global Genome Editing Market Outlook, By Crispr/Cas9 Nickase (2013-2022) ($MN)
16 Global Genome Editing Market Outlook, By Transcription Activator-Like Effector Nucleases (Talen) (2013-2022) ($MN)
17 Global Genome Editing Market Outlook, By Zinc Finger Nuclease (Zfn) (2013-2022) ($MN)
18 Global Genome Editing Market Outlook, By Antisense Technology (2013-2022) ($MN)
19 Global Genome Editing Market Outlook, By Other Technologies (2013-2022) ($MN)
20 Global Genome Editing Market Outlook, By Arcus (Homing Endonuclease) And Megatal (2013-2022) ($MN)
21 Global Genome Editing Market Outlook, By Recombinant Adeno-Associated Virus (R Aav) (2013-2022) ($MN)
22 Global Genome Editing Market Outlook, By Targatt And Rapid Trait Development System (Rtds) (2013-2022) ($MN)
23 Global Genome Editing Market Outlook, By Piggybac Transposase And Sleeping Beauty Transposon (2013-2022) ($MN)
24 Global Genome Editing Market Outlook, By Application (2013-2022) ($MN)
25 Global Genome Editing Market Outlook, By Plant Biotechnology/Agriculture (2013-2022) ($MN)
26 Global Genome Editing Market Outlook, By Drug Discovery And Development (2013-2022) ($MN)
27 Global Genome Editing Market Outlook, By Clinical (2013-2022) ($MN)
28 Global Genome Editing Market Outlook, By Pre-Clinical (2013-2022) ($MN)
29 Global Genome Editing Market Outlook, By Basic Research (2013-2022) ($MN)
30 Global Genome Editing Market Outlook, By Genomic Visualization (2013-2022) ($MN)
31 Global Genome Editing Market Outlook, By Genomic Screening (2013-2022) ($MN)
32 Global Genome Editing Market Outlook, By Transcription Activation/Repression (2013-2022) ($MN)
33 Global Genome Editing Market Outlook, By Animal Biotechnology (2013-2022) ($MN)
34 Global Genome Editing Market Outlook, By Livestock (2013-2022) ($MN)
35 Global Genome Editing Market Outlook, By Animal Health (2013-2022) ($MN)
36 Global Genome Editing Market Outlook, By Other Animal Biotechnology (2013-2022) ($MN)
37 Global Genome Editing Market Outlook, By Cell Line Engineering (2013-2022) ($MN)
38 Global Genome Editing Market Outlook, By End User (2013-2022) ($MN)
39 Global Genome Editing Market Outlook, By Pharmaceutical And Biotechnology Companies (2013-2022) ($MN)
40 Global Genome Editing Market Outlook, By Academic And Government Research Institutes (2013-2022) ($MN)
41 Global Genome Editing Market Outlook, By Plant Biotechnology Companies (2013-2022) ($MN)
42 Global Genome Editing Market Outlook, By Others End Users (2013-2022) ($MN)
43 Global Genome Editing Market Outlook, By Contract Research Organizations (Cro) (2013-2022) ($MN)
44 Global Genome Editing Market Outlook, By Animal Biotechnology (2013-2022) ($MN)
45 North America Genome Editing Market Outlook, By Country (2013-2022) ($MN)
46 North America Genome Editing Market Outlook, By Products And Services (2013-2022) ($MN)
47 North America Genome Editing Market Outlook, By Genome Editing Services (2013-2022) ($MN)
48 North America Genome Editing Market Outlook, By Software (2013-2022) ($MN)
49 North America Genome Editing Market Outlook, By Reagents, Enzymes And Consumables (2013-2022) ($MN)
50 North America Genome Editing Market Outlook, By Delivery Tools (2013-2022) ($MN)
51 North America Genome Editing Market Outlook, By Genome Editing Tools And Kits (2013-2022) ($MN)
52 North America Genome Editing Market Outlook, By Other Reagents, Enzymes And Consumables (2013-2022) ($MN)
53 North America Genome Editing Market Outlook, By Instruments (2013-2022) ($MN)
54 North America Genome Editing Market Outlook, By Cell Lines And Animal Models (2013-2022) ($MN)
55 North America Genome Editing Market Outlook, By Technology (2013-2022) ($MN)
56 North America Genome Editing Market Outlook, By Clustered Regularly Interspaced Short Palindromic Repeats (Crispr/Cas9) (2013-2022) ($MN)
57 North America Genome Editing Market Outlook, By Crispr Dcas9 (2013-2022) ($MN)
58 North America Genome Editing Market Outlook, By Wt Crispr/Cas9 (2013-2022) ($MN)
59 North America Genome Editing Market Outlook, By Crispr/Cas9 Nickase (2013-2022) ($MN)
60 North America Genome Editing Market Outlook, By Transcription Activator-Like Effector Nucleases (Talen) (2013-2022) ($MN)
61 North America Genome Editing Market Outlook, By Zinc Finger Nuclease (Zfn) (2013-2022) ($MN)
62 North America Genome Editing Market Outlook, By Antisense Technology (2013-2022) ($MN)
63 North America Genome Editing Market Outlook, By Other Technologies (2013-2022) ($MN)
64 North America Genome Editing Market Outlook, By Arcus (Homing Endonuclease) And Megatal (2013-2022) ($MN)
65 North America Genome Editing Market Outlook, By Recombinant Adeno-Associated Virus (R Aav) (2013-2022) ($MN)
66 North America Genome Editing Market Outlook, By Targatt And Rapid Trait Development System (Rtds) (2013-2022) ($MN)
67 North America Genome Editing Market Outlook, By Piggybac Transposase And Sleeping Beauty Transposon (2013-2022) ($MN)
68 North America Genome Editing Market Outlook, By Application (2013-2022) ($MN)
69 North America Genome Editing Market Outlook, By Plant Biotechnology/Agriculture (2013-2022) ($MN)
70 North America Genome Editing Market Outlook, By Drug Discovery And Development (2013-2022) ($MN)
71 North America Genome Editing Market Outlook, By Clinical (2013-2022) ($MN)
72 North America Genome Editing Market Outlook, By Pre-Clinical (2013-2022) ($MN)
73 North America Genome Editing Market Outlook, By Basic Research (2013-2022) ($MN)
74 North America Genome Editing Market Outlook, By Genomic Visualization (2013-2022) ($MN)
75 North America Genome Editing Market Outlook, By Genomic Screening (2013-2022) ($MN)
76 North America Genome Editing Market Outlook, By Transcription Activation/Repression (2013-2022) ($MN)
77 North America Genome Editing Market Outlook, By Animal Biotechnology (2013-2022) ($MN)
78 North America Genome Editing Market Outlook, By Livestock (2013-2022) ($MN)
79 North America Genome Editing Market Outlook, By Animal Health (2013-2022) ($MN)
80 North America Genome Editing Market Outlook, By Other Animal Biotechnology (2013-2022) ($MN)
81 North America Genome Editing Market Outlook, By Cell Line Engineering (2013-2022) ($MN)
82 North America Genome Editing Market Outlook, By End User (2013-2022) ($MN)
83 North America Genome Editing Market Outlook, By Pharmaceutical And Biotechnology Companies (2013-2022) ($MN)
84 North America Genome Editing Market Outlook, By Academic And Government Research Institutes (2013-2022) ($MN)
85 North America Genome Editing Market Outlook, By Plant Biotechnology Companies (2013-2022) ($MN)
86 North America Genome Editing Market Outlook, By Others End Users (2013-2022) ($MN)
87 North America Genome Editing Market Outlook, By Contract Research Organizations (Cro) (2013-2022) ($MN)
88 North America Genome Editing Market Outlook, By Animal Biotechnology (2013-2022) ($MN)
89 Europe Genome Editing Market Outlook, By Country (2013-2022) ($MN)
90 Europe Genome Editing Market Outlook, By Products And Services (2013-2022) ($MN)
91 Europe Genome Editing Market Outlook, By Genome Editing Services (2013-2022) ($MN)
92 Europe Genome Editing Market Outlook, By Software (2013-2022) ($MN)
93 Europe Genome Editing Market Outlook, By Reagents, Enzymes And Consumables (2013-2022) ($MN)
94 Europe Genome Editing Market Outlook, By Delivery Tools (2013-2022) ($MN)
95 Europe Genome Editing Market Outlook, By Genome Editing Tools And Kits (2013-2022) ($MN)
96 Europe Genome Editing Market Outlook, By Other Reagents, Enzymes And Consumables (2013-2022) ($MN)
97 Europe Genome Editing Market Outlook, By Instruments (2013-2022) ($MN)
98 Europe Genome Editing Market Outlook, By Cell Lines And Animal Models (2013-2022) ($MN)
99 Europe Genome Editing Market Outlook, By Technology (2013-2022) ($MN)
100 Europe Genome Editing Market Outlook, By Clustered Regularly Interspaced Short Palindromic Repeats (Crispr/Cas9) (2013-2022) ($MN)
101 Europe Genome Editing Market Outlook, By Crispr Dcas9 (2013-2022) ($MN)
102 Europe Genome Editing Market Outlook, By Wt Crispr/Cas9 (2013-2022) ($MN)
103 Europe Genome Editing Market Outlook, By Crispr/Cas9 Nickase (2013-2022) ($MN)
104 Europe Genome Editing Market Outlook, By Transcription Activator-Like Effector Nucleases (Talen) (2013-2022) ($MN)
105 Europe Genome Editing Market Outlook, By Zinc Finger Nuclease (Zfn) (2013-2022) ($MN)
106 Europe Genome Editing Market Outlook, By Antisense Technology (2013-2022) ($MN)
107 Europe Genome Editing Market Outlook, By Other Technologies (2013-2022) ($MN)
108 Europe Genome Editing Market Outlook, By Arcus (Homing Endonuclease) And Megatal (2013-2022) ($MN)
109 Europe Genome Editing Market Outlook, By Recombinant Adeno-Associated Virus (R Aav) (2013-2022) ($MN)
110 Europe Genome Editing Market Outlook, By Targatt And Rapid Trait Development System (Rtds) (2013-2022) ($MN)
111 Europe Genome Editing Market Outlook, By Piggybac Transposase And Sleeping Beauty Transposon (2013-2022) ($MN)
112 Europe Genome Editing Market Outlook, By Application (2013-2022) ($MN)
113 Europe Genome Editing Market Outlook, By Plant Biotechnology/Agriculture (2013-2022) ($MN)
114 Europe Genome Editing Market Outlook, By Drug Discovery And Development (2013-2022) ($MN)
115 Europe Genome Editing Market Outlook, By Clinical (2013-2022) ($MN)
116 Europe Genome Editing Market Outlook, By Pre-Clinical (2013-2022) ($MN)
117 Europe Genome Editing Market Outlook, By Basic Research (2013-2022) ($MN)
118 Europe Genome Editing Market Outlook, By Genomic Visualization (2013-2022) ($MN)
119 Europe Genome Editing Market Outlook, By Genomic Screening (2013-2022) ($MN)
120 Europe Genome Editing Market Outlook, By Transcription Activation/Repression (2013-2022) ($MN)
121 Europe Genome Editing Market Outlook, By Animal Biotechnology (2013-2022) ($MN)
122 Europe Genome Editing Market Outlook, By Livestock (2013-2022) ($MN)
123 Europe Genome Editing Market Outlook, By Animal Health (2013-2022) ($MN)
124 Europe Genome Editing Market Outlook, By Other Animal Biotechnology (2013-2022) ($MN)
125 Europe Genome Editing Market Outlook, By Cell Line Engineering (2013-2022) ($MN)
126 Europe Genome Editing Market Outlook, By End User (2013-2022) ($MN)
127 Europe Genome Editing Market Outlook, By Pharmaceutical And Biotechnology Companies (2013-2022) ($MN)
128 Europe Genome Editing Market Outlook, By Academic And Government Research Institutes (2013-2022) ($MN)
129 Europe Genome Editing Market Outlook, By Plant Biotechnology Companies (2013-2022) ($MN)
130 Europe Genome Editing Market Outlook, By Others End Users (2013-2022) ($MN)
131 Europe Genome Editing Market Outlook, By Contract Research Organizations (Cro) (2013-2022) ($MN)
132 Europe Genome Editing Market Outlook, By Animal Biotechnology (2013-2022) ($MN)
133 Asia Pacific Genome Editing Market Outlook, By Country (2013-2022) ($MN)
134 Asia Pacific Genome Editing Market Outlook, By Products And Services (2013-2022) ($MN)
135 Asia Pacific Genome Editing Market Outlook, By Genome Editing Services (2013-2022) ($MN)
136 Asia Pacific Genome Editing Market Outlook, By Software (2013-2022) ($MN)
137 Asia Pacific Genome Editing Market Outlook, By Reagents, Enzymes And Consumables (2013-2022) ($MN)
138 Asia Pacific Genome Editing Market Outlook, By Delivery Tools (2013-2022) ($MN)
139 Asia Pacific Genome Editing Market Outlook, By Genome Editing Tools And Kits (2013-2022) ($MN)
140 Asia Pacific Genome Editing Market Outlook, By Other Reagents, Enzymes And Consumables (2013-2022) ($MN)
141 Asia Pacific Genome Editing Market Outlook, By Instruments (2013-2022) ($MN)
142 Asia Pacific Genome Editing Market Outlook, By Cell Lines And Animal Models (2013-2022) ($MN)
143 Asia Pacific Genome Editing Market Outlook, By Technology (2013-2022) ($MN)
144 Asia Pacific Genome Editing Market Outlook, By Clustered Regularly Interspaced Short Palindromic Repeats (Crispr/Cas9) (2013-2022) ($MN)
145 Asia Pacific Genome Editing Market Outlook, By Crispr Dcas9 (2013-2022) ($MN)
146 Asia Pacific Genome Editing Market Outlook, By Wt Crispr/Cas9 (2013-2022) ($MN)
147 Asia Pacific Genome Editing Market Outlook, By Crispr/Cas9 Nickase (2013-2022) ($MN)
148 Asia Pacific Genome Editing Market Outlook, By Transcription Activator-Like Effector Nucleases (Talen) (2013-2022) ($MN)
149 Asia Pacific Genome Editing Market Outlook, By Zinc Finger Nuclease (Zfn) (2013-2022) ($MN)
150 Asia Pacific Genome Editing Market Outlook, By Antisense Technology (2013-2022) ($MN)
151 Asia Pacific Genome Editing Market Outlook, By Other Technologies (2013-2022) ($MN)
152 Asia Pacific Genome Editing Market Outlook, By Arcus (Homing Endonuclease) And Megatal (2013-2022) ($MN)
153 Asia Pacific Genome Editing Market Outlook, By Recombinant Adeno-Associated Virus (R Aav) (2013-2022) ($MN)
154 Asia Pacific Genome Editing Market Outlook, By Targatt And Rapid Trait Development System (Rtds) (2013-2022) ($MN)
155 Asia Pacific Genome Editing Market Outlook, By Piggybac Transposase And Sleeping Beauty Transposon (2013-2022) ($MN)
156 Asia Pacific Genome Editing Market Outlook, By Application (2013-2022) ($MN)
157 Asia Pacific Genome Editing Market Outlook, By Plant Biotechnology/Agriculture (2013-2022) ($MN)
158 Asia Pacific Genome Editing Market Outlook, By Drug Discovery And Development (2013-2022) ($MN)
159 Asia Pacific Genome Editing Market Outlook, By Clinical (2013-2022) ($MN)
160 Asia Pacific Genome Editing Market Outlook, By Pre-Clinical (2013-2022) ($MN)
161 Asia Pacific Genome Editing Market Outlook, By Basic Research (2013-2022) ($MN)
162 Asia Pacific Genome Editing Market Outlook, By Genomic Visualization (2013-2022) ($MN)
163 Asia Pacific Genome Editing Market Outlook, By Genomic Screening (2013-2022) ($MN)
164 Asia Pacific Genome Editing Market Outlook, By Transcription Activation/Repression (2013-2022) ($MN)
165 Asia Pacific Genome Editing Market Outlook, By Animal Biotechnology (2013-2022) ($MN)
166 Asia Pacific Genome Editing Market Outlook, By Livestock (2013-2022) ($MN)
167 Asia Pacific Genome Editing Market Outlook, By Animal Health (2013-2022) ($MN)
168 Asia Pacific Genome Editing Market Outlook, By Other Animal Biotechnology (2013-2022) ($MN)
169 Asia Pacific Genome Editing Market Outlook, By Cell Line Engineering (2013-2022) ($MN)
170 Asia Pacific Genome Editing Market Outlook, By End User (2013-2022) ($MN)
171 Asia Pacific Genome Editing Market Outlook, By Pharmaceutical And Biotechnology Companies (2013-2022) ($MN)
172 Asia Pacific Genome Editing Market Outlook, By Academic And Government Research Institutes (2013-2022) ($MN)
173 Asia Pacific Genome Editing Market Outlook, By Plant Biotechnology Companies (2013-2022) ($MN)
174 Asia Pacific Genome Editing Market Outlook, By Others End Users (2013-2022) ($MN)
175 Asia Pacific Genome Editing Market Outlook, By Contract Research Organizations (Cro) (2013-2022) ($MN)
176 Asia Pacific Genome Editing Market Outlook, By Animal Biotechnology (2013-2022) ($MN)
177 RoW Genome Editing Market Outlook, By Country (2013-2022) ($MN)
178 RoW Genome Editing Market Outlook, By Products And Services (2013-2022) ($MN)
179 RoW Genome Editing Market Outlook, By Genome Editing Services (2013-2022) ($MN)
180 RoW Genome Editing Market Outlook, By Software (2013-2022) ($MN)
181 RoW Genome Editing Market Outlook, By Reagents, Enzymes And Consumables (2013-2022) ($MN)
182 RoW Genome Editing Market Outlook, By Delivery Tools (2013-2022) ($MN)
183 RoW Genome Editing Market Outlook, By Genome Editing Tools and Kits (2013-2022) ($MN)
184 RoW Genome Editing Market Outlook, By Other Reagents, Enzymes and Consumables (2013-2022) ($MN)
185 RoW Genome Editing Market Outlook, By Instruments (2013-2022) ($MN)
186 RoW Genome Editing Market Outlook, By Cell Lines and Animal Models (2013-2022) ($MN)
187 RoW Genome Editing Market Outlook, By Technology (2013-2022) ($MN)
188 RoW Genome Editing Market Outlook, By Clustered Regularly Interspaced Short Palindromic Repeats (Crispr/Cas9) (2013-2022) ($MN)
189 RoW Genome Editing Market Outlook, By Crispr Dcas9 (2013-2022) ($MN)
190 RoW Genome Editing Market Outlook, By Wt Crispr/Cas9 (2013-2022) ($MN)
191 RoW Genome Editing Market Outlook, By Crispr/Cas9 Nickase (2013-2022) ($MN)
192 RoW Genome Editing Market Outlook, By Transcription Activator-Like Effector Nucleases (Talen) (2013-2022) ($MN)
193 RoW Genome Editing Market Outlook, By Zinc Finger Nuclease (Zfn) (2013-2022) ($MN)
194 RoW Genome Editing Market Outlook, By Antisense Technology (2013-2022) ($MN)
195 RoW Genome Editing Market Outlook, By Other Technologies (2013-2022) ($MN)
196 RoW Genome Editing Market Outlook, By Arcus (Homing Endonuclease) And Megatal (2013-2022) ($MN)
197 RoW Genome Editing Market Outlook, By Recombinant Adeno-Associated Virus (R Aav) (2013-2022) ($MN)
198 RoW Genome Editing Market Outlook, By Targatt and Rapid Trait Development System (Rtds) (2013-2022) ($MN)
199 RoW Genome Editing Market Outlook, By Piggybac Transposase And Sleeping Beauty Transposon (2013-2022) ($MN)
200 RoW Genome Editing Market Outlook, By Application (2013-2022) ($MN)
201 RoW Genome Editing Market Outlook, By Plant Biotechnology/Agriculture (2013-2022) ($MN)
202 RoW Genome Editing Market Outlook, By Drug Discovery and Development (2013-2022) ($MN)
203 RoW Genome Editing Market Outlook, By Clinical (2013-2022) ($MN)
204 RoW Genome Editing Market Outlook, By Pre-Clinical (2013-2022) ($MN)
205 RoW Genome Editing Market Outlook, By Basic Research (2013-2022) ($MN)
206 RoW Genome Editing Market Outlook, By Genomic Visualization (2013-2022) ($MN)
207 RoW Genome Editing Market Outlook, By Genomic Screening (2013-2022) ($MN)
208 RoW Genome Editing Market Outlook, By Transcription Activation/Repression (2013-2022) ($MN)
209 RoW Genome Editing Market Outlook, By Animal Biotechnology (2013-2022) ($MN)
210 RoW Genome Editing Market Outlook, By Livestock (2013-2022) ($MN)
211 RoW Genome Editing Market Outlook, By Animal Health (2013-2022) ($MN)
212 RoW Genome Editing Market Outlook, By Other Animal Biotechnology (2013-2022) ($MN)
213 RoW Genome Editing Market Outlook, By Cell Line Engineering (2013-2022) ($MN)
214 RoW Genome Editing Market Outlook, By End User (2013-2022) ($MN)
215 RoW Genome Editing Market Outlook, By Pharmaceutical and Biotechnology Companies (2013-2022) ($MN)
216 RoW Genome Editing Market Outlook, By Academic and Government Research Institutes (2013-2022) ($MN)
217 RoW Genome Editing Market Outlook, By Plant Biotechnology Companies (2013-2022) ($MN)
218 RoW Genome Editing Market Outlook, By Others End Users (2013-2022) ($MN)
219 RoW Genome Editing Market Outlook, By Contract Research Organizations (Cro) (2013-2022) ($MN)
220 RoW Genome Editing Market Outlook, By Animal Biotechnology (2013-2022) ($MN)
